SCHEMBL8023017

SCHEMBL8023017

Nc1ccc(S(N)(=O)=O)c(-c2ccccc2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 3/20 0.46
ALDH1A1 P00352 2/20 0.46
RAB9A P51151 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
CYP3A4 P08684 2/20 0.46
TDP1 Q9NUW8 2/20 0.46
TP53 P04637 1/20 0.46
TSHR P16473 1/20 0.46
MAPK1 P28482 1/20 0.46
PTPRC P08575 2/20 0.44
MEN1 O00255 1/20 0.44
APAF1 O14727 1/20 0.44
TDP2 O95551 1/20 0.44
NSD2 O96028 1/20 0.44
LMNA P02545 1/20 0.44
PLA2G1B P04054 1/20 0.44
POLB P06746 1/20 0.44
CTSL P07711 1/20 0.44
HPGD P15428 1/20 0.44
ALOX12 P18054 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30687380 1.00 NPC1 (0.46) NPC1ALDH1A1RAB9ASMN1; SMN2CYP3A4
SCHEMBL671916 0.89 CA1 (0.50) NPC1ALDH1A1RAB9ASMN1; SMN2CYP3A4
SCHEMBL11743126 0.87 ALDH1A1 (0.47) NPC1ALDH1A1RAB9ASMN1; SMN2CYP3A4
SCHEMBL2272811 0.84 ALDH1A1 (0.51) NPC1ALDH1A1RAB9ASMN1; SMN2CYP3A4
SCHEMBL11882155 0.82 AKT1 (0.44) CA1CA2CA12CA9CA4
SCHEMBL8012548 0.82 CA1 (0.51) CA1CA2CA12CA9CA14
SCHEMBL27842438 0.80 CA1 (0.54) CA1CA2CA12CA9CA4
SCHEMBL8597605 0.80 HDAC7 (0.45) ALDH1A1LMNAPOLBHPGDALOX12
SCHEMBL28469382 0.80 PTGES2 (0.51) KMT2ACA1CA2CA12CA9
SCHEMBL672207 0.80 CA1 (0.52) NPC1ALDH1A1RAB9ASMN1; SMN2CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-107635986-A Substituted quinoxaline derivatives 赛尔维他股份公司 2018-01-26 CN claimed
CN-117561081-A Application of CYP450 inhibitor in inhibiting or killing mites and treating xerophthalmia 广州珍实视界生物医药科技有限公司 2024-02-13 CN disclosed
CN-114573586-B Polycyclic compound for inhibiting Bruton tyrosine kinase activity, pharmaceutical composition and application thereof 杭州和正医药有限公司 2023-11-03 CN disclosed
CN-110672843-A Quintuplet time-resolved fluoroimmunoassay test strip for quantitatively determining sulfonamides 南京海关动植物与食品检测中心 2020-01-10 CN disclosed
CN-108349282-A Thermal recording medium and diphenyl sulphone (DPS) 日本化药株式会社 2018-07-31 CN disclosed
CN-107635986-A Substituted quinoxaline derivatives 赛尔维他股份公司 2018-01-26 CN disclosed
CN-102958971-B Epoxy polycyclopentadiene compounds DOW GLOBAL TECHNOLOGIES INC 2014-12-31 CN disclosed
CN-102958971-A Epoxy polycyclopentadiene compounds DOW GLOBAL TECHNOLOGIES LLC 2013-03-06 CN disclosed
US-6127150-A VECTOR FOR THE EFFICIENT EXPRESSION AND ISOLATION OF HETEROLOGOUS PROTEINS BIONEBRASKA, INC. (US) 2000-10-03 US disclosed
EP-0539530-B1 PURIFICATION DIRECTED CLONING OF PEPTIDES BIONEBRASKA INC (US) 2000-02-02 EP disclosed
US-5595887-A GENE EXPRESSION, FORMING POLYPEPTIDES FOR PROTEIN PURIFICATION BIONEBRASKA, INC. (US) 1997-01-21 US disclosed
US-5510387-A ADMINISTERING A CRYSTALLINE GAMMA-MODIFICATION OF PARA-AMINOBENZENESULFANILAMIDE Leonidov, Nikolai Borisovich (RU) 1996-04-23 US disclosed
EP-0539530-A4 PURIFICATION DIRECTED CLONING OF PEPTIDES. 1993-09-15 EP disclosed
EP-0539530-A1 PURIFICATION DIRECTED CLONING OF PEPTIDES BIONEBRASKA, INC. (US) 1993-05-05 EP disclosed
WO-1992001707-A1 PURIFICATION DIRECTED CLONING OF PEPTIDES BIONEBRASKA, INC. (US) 1992-02-06 WO disclosed
CN-85101429-B Microcapsules and process for making microcapsules 斯多佛化学有限公司 1988-08-17 CN disclosed
CN-85101429-A The process of microencapsulation and preparing microcapsules 1987-01-17 CN disclosed